ArticleJAMA network open2021

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.

Sietske C van Nassau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.